DAVID VRANE

Insider profile

DAVID VRANE's trades of Cytek Biosciences Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
230.37
Quantity 54,768
Value US$268,041
Transaction date
Proposed sale
Price
145.78
Quantity 4,647
Value US$3,911,081
Transaction date
Proposed sale
Price
74.26
Quantity 29,924
Value US$172,068
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-11-15 2023-11-15 PrS Proposed sale
54,768
230.37
US$268,041
54,768 230.37 US$268,041
2023-08-14 2023-08-14 PrS Proposed sale
4,647
145.78
US$3,911,081
4,647 145.78 US$3,911,081
2023-05-15 2023-05-15 PrS Proposed sale
29,924
74.26
US$172,068
29,924 74.26 US$172,068